Actualizado el 17/12/2024
Actualizado el 17/12/2024
Optomed announces new investment from RBVCEscrito por Redacción TNI el 06/10/2015 a las 21:20:561565
“This investment will be used to accelerate growth across the business, to advance our product development and help us to successfully execute our strategy. It is a big recognition towards both our technology and our team in Finland. We are proud to welcome RBVC as one of our investors. With their support we are growing into a truly global company,” says Seppo Kopsala, CEO of Optomed.
“Worldwide increase of chronic diseases as Diabetes leading to severe eye diseases in developed countries and emerging markets requires retina screening solutions. In order to diagnose and successfully treat such diseases in early stages it helps to reduce or prevent blindness. The Optomed approach convinced us as it offers a least cost approach with excellent technical performance on a worldwide basis. It opens huge opportunities,” says Dr. Dieter Kraft, Investment Partner of RBVC.
Optomed provides most affordable and effective fundus screening and diagnostics products and solutions that can reach all people in the world and help eye care professionals in prevention of blindness. Optomed’s products are being used by private clinics, public hospitals, non-government organizations and charities around the world, and are registered and marketed in all major markets: Europe, China, Russia, Japan, Korea, US, India and Brazil. |
